This Fast Track Designation will enable FDA to review MM-II in an expedited manner, is an important milestone in the development of MM-II
The initiation of a second Phase 3 clinical trial for bomedemstat demonstrates company’s commitment to advancing research in myeloproliferative neoplasms (MPNs)
Bortezomib Injection is approved for subcutaneous or intravenous use. It is available as a single dose vial of 3.5 mg/1.4 mL (2.5 mg/mL)
e brings over 27+ years of rich pharmaceutical experience
Nor UDCA is likely to be a first-in-class treatment option for NAFLD in India
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
This product will be manufactured by Indoco at its manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa in India
This two-day program was attended by 40 doctors & paramedical staff
The sales of medicines and other items sold through Jan Aushadhi Kendras have increased from Rs. 7.29 crore in 2014 to Rs. 1,470 crore by July 2024
Nearly 200 participants from 50 Unani Academia and Council participated
Subscribe To Our Newsletter & Stay Updated
